- 专利标题: Fused pentacyclic imidazole derivatives as modulators of TNF activity
-
申请号: US17284950申请日: 2019-10-23
-
公开(公告)号: US11554122B2公开(公告)日: 2023-01-17
- 发明人: James Andrew Johnson , Ellen Olivia Gallimore , Mengyang Xuan
- 申请人: UCB Biopharma SRL , SANOFI
- 申请人地址: BE Brussels; FR Paris
- 专利权人: UCB Biopharma SRL,SANOFI
- 当前专利权人: UCB Biopharma SRL,SANOFI
- 当前专利权人地址: BE Brussels; FR Paris
- 代理机构: McDonnell Boehnen Hulbert & Berghoff LLP
- 优先权: EP18275165 20181024
- 国际申请: PCT/EP2019/078922 WO 20191023
- 国际公布: WO2020/084008 WO 20200430
- 主分类号: A61K31/55
- IPC分类号: A61K31/55 ; C07D471/18 ; C07D487/18
摘要:
A compound of formula (I) as defined herein, or a pharmaceutically acceptable salt thereof, being potent modulators of human TNF a activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
公开/授权文献
信息查询